Pharmaceutical glass tubing is used to package various pharma drugs and injections used in healthcare. Ranging from simple glass vials to complex multidose cartridges, glass tubing provides a sterile and chemically inert solution for packaging pharmaceutical products. Glass avoids interaction between drugs and packaging material and facilitates visual inspection.

The global pharmaceutical glass tubing Market is estimated to be valued at US$ 8.3 Bn or Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023-2030, as highlighted in a new report published by CoherentMI.

Market Dynamics:

The pharmaceutical glass tubing market is primarily driven by the rising demand for glass packaging in the pharmaceutical industry. Glass is considered the gold standard for pharmaceutical packaging due to its inertness, low levels of interaction with drugs, and transparency allowing visual inspection. As the pharmaceutical industry grows with new drug launches and rising healthcare spends across regions, the demand for pharmaceutical glass tubing for packaging these drugs is also increasing. The second driver for this market is the superior properties of glass such as recyclability and reuse. Pharma glass being 100% recyclable aids in reduction of waste from the packaging process. This sustainability aspect is an important factor considered by pharmaceutical manufacturers and is influencing increased adoption of glass tubing.

SWOT Analysis:

Strength: Pharmaceutical glass tubing has high durability and biocompatibility making it suitable for packaging injectable drugs and vials. Its chemical resistance allows for storage of pharmaceutical solutions without interactions. The material is non-reactive, inert and transparent allowing visualization of contents.

Weakness: High raw material and manufacturing costs associated with pharmaceutical grade glass results in relatively higher product prices. Rigid quality control procedures and certification requirements further add to expenses. Fragility remains a handling challenge requiring specialized packaging and transportation.

Opportunity: Growing global demand for injectable drug delivery driven by increasing prevalence of chronic diseases and aging population. Rising biologics drug approvals are expanding application scope of prefilled syringes and self-injection devices driving pharma tubing consumption. Development of sophisticated tubing processing capabilities for specialized delivery mechanisms present new opportunities.

Threats: Availability of alternative polymer packaging materials posing substitution threat. Stringent regulations around contaminants and breakages add compliance pressures on manufacturers. Trade protectionism and sanctions in key markets introduce supply uncertainties.

Global Pharmaceutical Glass Tubing Market Segmentation:

  • By Product Type
  • Vials
  • Ampoules
  • Cartridges
  • Syringes
  • Bottles
  • Others (Tubes, Rods, Stoppers etc.)
  •  By End User
  • Pharmaceutical
  • Biotechnology
  • Diagnostics
  • Chemical
  • Others (Research, Forensics etc.)
  •  By Distribution Channel
  • Direct Sales
  • Distributors
  • Online
  • Others
  •  By Manufacturing Process
  • Tubing
  • Molding
  • Extrusion
  • Others

Key Takeaways:

The global Pharmaceutical Glass Tubing Market Size is expected to witness high growth over the forecast period of 2023-2030. The market size is projected to reach US$ 8.3 Billion by 2023 exhibiting a CAGR of 7.1% during the period.

North America dominates currently accounting for over 35% share attributed to robust healthcare spending, strong production capabilities and concentration of leading drug makers in the region. Asia Pacific is the fastest growing market led by China, India and other emerging economies on back of expanding local pharma manufacturing industries and improving access to healthcare.

Key players operating in the Pharmaceutical Glass Tubing market are Schott AG, Nipro Pharma Corporation, Corning Incorporated, NEG Glass, Shandong Pharmaceutical Glass Co., Ltd., Borosil Glass Works Ltd., Thermo Fisher Scientific, Richland Glass, Haldyn Glass Ltd., Duran Group GmbH, Epax Systems, Linuo Group Glass Products Co., Ltd., JSG Pharma, Fushan Technology, NAFEMS, Saverglass Group, Division of Berlin Packaging. Schott AG and Nipro Pharma Corporation hold leading market positions.

Get More Insights on This Topic : https://www.articledistrict.com/the-pharmaceutical-glass-tubing-market-accelerated-by-increasing-demand/